Due to the approval as a COVID-19 treatment, until the end of next year, worldwide sales of Gilead Science's antiviral drug Veklury (remdesivir) is expected to increase to over *** U.S. dollars. This statistic shows the sales forecast of remdesivir - trademarked as Veklury - worldwide from 2020 to 2026.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Evaluate Vantage. (July 31, 2020). Sales forecast of Veklury (remdesivir) worldwide from 2020 to 2026 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 21, 2026, from /statistics/1143040/remdesivir-sales-forecast-worldwide/
Evaluate Vantage. "Sales forecast of Veklury (remdesivir) worldwide from 2020 to 2026 (in million U.S. dollars)." Chart. July 31, 2020. ÌÇÐÄÆƽâ°æ. Accessed July 21, 2026. /statistics/1143040/remdesivir-sales-forecast-worldwide/
Evaluate Vantage. (2020). Sales forecast of Veklury (remdesivir) worldwide from 2020 to 2026 (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 21, 2026. /statistics/1143040/remdesivir-sales-forecast-worldwide/
Evaluate Vantage. "Sales Forecast of Veklury (Remdesivir) Worldwide from 2020 to 2026 (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 31 Jul 2020, /statistics/1143040/remdesivir-sales-forecast-worldwide/
Evaluate Vantage, Sales forecast of Veklury (remdesivir) worldwide from 2020 to 2026 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1143040/remdesivir-sales-forecast-worldwide/ (last visited July 21, 2026)
Sales forecast of Veklury (remdesivir) worldwide from 2020 to 2026 (in million U.S. dollars) [Graph], Evaluate Vantage, July 31, 2020. [Online]. Available: /statistics/1143040/remdesivir-sales-forecast-worldwide/
